Picture of Gelstat logo

GSAC Gelstat Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Gelstat, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2013
December 31st
2014
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSPROSPECTUSPROSPECTUSPROSPECTUS
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-0.407-1.3-0.178-0.475-0.761
Depreciation
Non-Cash Items0.250.9110-0.0280.314
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.010.090.0930.2990.274
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-0.145-0.239-0.085-0.205-0.172
Capital Expenditures-0.003-0.005
Purchase of Fixed Assets
Other Investing Cash Flow Items-0.007-0.193000
Acquisition of Business
Other Investing Cash Flow
Cash from Investing Activities-0.01-0.197000
Financing Cash Flow Items0
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.2490.4380.0850.2710.107
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.0940.002-00.066-0.065